Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 9.16 INR
Change Today 0.00 / 0.00%
Volume 0.0
VSP On Other Exchanges
Symbol
Exchange
Mumbai
As of 7:40 AM 06/24/14 All times are local (Market data is delayed by at least 15 minutes).

vista pharmaceuticals ltd (VSP) Snapshot

Open
17.25
Previous Close
9.16
Day High
17.25
Day Low
15.00
52 Week High
04/24/15 - 13.25
52 Week Low
08/5/14 - 4.80
Market Cap
228.0M
Average Volume 10 Days
0.0
EPS TTM
0.33
Shares Outstanding
24.9M
EX-Date
--
P/E TM
28.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for VISTA PHARMACEUTICALS LTD (VSP)

Related News

No related news articles were found.

vista pharmaceuticals ltd (VSP) Related Businessweek News

No Related Businessweek News Found

vista pharmaceuticals ltd (VSP) Details

Vista Pharmaceuticals Limited manufactures and sells pharmaceutical products. It offers over the counter and prescription generic drug products consisting of tablets, capsules, and liquids covering various therapeutic categories. The company also exports its products. Vista Pharmaceuticals Limited was incorporated in 1991 and is based in Hyderabad, India.

vista pharmaceuticals ltd (VSP) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

vista pharmaceuticals ltd (VSP) Key Developments

Vista Pharmaceuticals Limited, Board Meeting, Jul 02, 2015

Vista Pharmaceuticals Limited, Board Meeting, Jul 02, 2015. Agenda: To consider split and issue of new share certificates pursuant to the scheme of reduction of share capital of the company, as approved by the Hon'ble High Court of Andhra Pradesh and Telangana.

Vista Pharmaceuticals Limited Reports Unaudited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2015

Vista Pharmaceuticals Limited reported unaudited standalone earnings results for the fourth quarter and full year ended March 31, 2015. For the quarter, the company reported net sales or income from operations of INR 25.137 million compared to INR 54.319 million a year ago. Profit from operations before other income, interest and exceptional items were INR 3.284 million compared to INR 13.370 million a year ago. Profit from ordinary activities before tax was INR 2.180 million compared to INR 13.370 million a year ago. Net profit was INR 2.180 million or INR 0.09 per basic and diluted share before and after extraordinary items compared to INR 13.370 million or INR 0.89 per basic and diluted share before and after extraordinary items a year ago. For the year, the company reported net sales or income from operations of INR 137.466 million compared to INR 83.016 million a year ago. Profit from operations before other income, interest and exceptional items were INR 16.602 million compared to INR 4.435 million a year ago. Profit from ordinary activities before tax was INR 12.565 million compared to INR 4.732 million a year ago. Net profit was INR 13.616 million or INR 0.54 per basic and diluted share before and after extraordinary items compared to INR 4.668 million or INR 0.31 per basic and diluted share before and after extraordinary items a year ago.

Vista Pharmaceuticals Limited, Board Meeting, May 28, 2015

Vista Pharmaceuticals Limited, Board Meeting, May 28, 2015. Agenda: To consider audited results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VSP:IN 9.16 INR 0.00

VSP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Lannett Co Inc $56.18 USD -0.44
Mallinckrodt PLC $123.08 USD -0.74
Mylan NV $56.37 USD -9.57
Novartis AG SFr.97.85 CHF -0.80
View Industry Companies
 

Industry Analysis

VSP

Industry Average

Valuation VSP Industry Range
Price/Earnings 27.1x
Price/Sales 2.6x
Price/Book 3.4x
Price/Cash Flow 9.1x
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VISTA PHARMACEUTICALS LTD, please visit www.vistapharmaceuticals.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.